Clinical Trial Update: REDUCE Trial- Reducing Prolapse Recurrence [NA]

View source ↗

Summary

The REDUCE trial evaluating reducing prolapse recurrence in female patients is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pelvic Organ Prolapse

Snippet

Sponsor: Northwestern University | Conditions: Prolapse; Female | NA | Status: ACTIVE_NOT_RECRUITING